Has pharma fully acknowledged the power of rapid-dissolve tablet technologies?

Precious metals-bearing catalysts are essential in some pharma processes – but, once they’re spent, they still hold value.

Salicylanilides have been a reliable treatment against tapeworms for much of pharma’s history. Now, they could be used to help fight COVID-19.

The question that’s on everyone’s lips: how can developers tackle solid tumors and bring cell therapy to millions?

What strategies can pharma employ to protect itself against cyber threats?

How to streamline a rapidly expanding field? Joe Garrity of Lonza discusses the pain points and easily missed fixes.

Looking to pivot your business model to a CDMO service offering? Here’s what to keep in mind.

Eli Lilly’s Loxo Oncology has signed a deal with Yi Liu’s Kumquat Biosciences, targeting novel small molecules for immuno-oncology.

Google’s DeepMind has opened its AlphaFold protein structure database to the world.

How can we maximize the potential and production of potentially life-saving therapies?